Business
CLPS Incorporation's Growth Strategies Unaffected by COVID-19; Remains Prepared for Growing Demand for Its Services
SHANGHAI, March 20, 2020 /PRNewswire/ -- CLPS Incorporation (Nasdaq: CLPS) ("CLPS" or "the Company"), today announced that its growth strategies remain
About this update from Clps Incorporation
[{"type":"text","content":"SHANGHAI, March 20, 2020 /PRNewswire/ -- CLPS Incorporation (Nasdaq: CLPS) (\"CLPS\" or \"the Company\"), today announced that its growth strategies remain unaffected by the global outbreak of the coronavirus disease (COVID-19) since January 2020. In addition, as part of the effort to combat the COVID-19 global outbreak, CLPS has enhanced its support to its clients in the healthcare industry. At the same time, CLPS remains well-equipped to meet the growing demand of its services.\nUpon learning about the outbreak in January, CLPS took the initiative to establish an internal COVID-19 Outbreak Response Group to minimize the impact of COVID-19 and to ensure the safety of its staff. Spearheaded by the Chairman of the Company, 20 additional management staff have proactively participated in this initiative, including the CEO, the COO, the acting CFO, the general manager of each business group, and the functional department heads. Since its founding, the response group has routinely monitored employee health through the \"CLPS Staff Health Status Tracking Questionnaire\" daily health survey, powered by an independent cloud-based application. The survey helps management understand the necessary preparations and arrangements to be made before and after a staff member returns to work based on the information provided in the survey, the availability of the Company's medical resources, and local government policies, among others. As of the date of this press release, CLPS has zero confirmed cases of COVID-19 amongst its staff.\nIn addition, at the height of the COVID-19 outbreak in China, CLPS enhanced its level of support for services provided to its clients in the healthcare industry, such as in the areas of research and development, testing, and maintenance of diagnostic medical imaging equipment including PHILIPS and AGFA. CLPS remains committed to its social responsibilities and is dedicated to fighting against the COVID-19 outbreak.\nMr. Paul Yang, Chairman and President of CLPS, commented, \"CLPS has taken progressive precautionary measures to ensure that our staff are protected against the novel coronavirus while doing our best to optimize our operations. I am confident that through cooperative and prudent action, we can soon overcome this outbreak. This ongoing crisis has not affected the growth strategies of CLPS thus far. We rema...